An overview of the serpin superfamily
By R. Law, Qingwei Zhang, S. McGowan, Ashley M. Buckle, G. Silverman, W. Wong, Carlos J. Rosado, C. Langendorf, R. Pike, Philip I Bird and 1 more. Genome Biology, 2006
706 citations recorded by the source corpus.
Serpins are a broadly distributed family of protease inhibitors that use a conformational change to inhibit target enzymes. They are central in controlling many important proteolytic cascades, including the mammalian coagulation pathways. Serpins are conformationally labile and many of the disease-linked mutations of serpins result in misfolding or in pathogenic, inactive polymers.
Subfields: Cancer Research, Cell Biology, Hematology
View Paper: https://www.semanticscholar.org/paper/f00a046576e1159ff1f3073f1f99fb4a42c9b97e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Cell Biology
In Hematology
Citations in the corpus
- Death by a thousand cuts: granzyme pathways of programmed cell death. (2008, background): “Serpins are the largest and most broadly distributed superfamily of protease inhibitors, with more than 1500 family members (88, 89).”
- Plant protease inhibitors: a defense strategy in plants (2007, background): “pathways involved in up-regulating the host immune response (Law et al., 2006).”
- Serpins Promote Cancer Cell Survival and Vascular Cooption in Brain Metastasis (2014, neutral): “Four serpins (NS and serpins B2, E1, and E2) selectively inhibit PA (Law et al., 2006).”
- Consensus protein design (2016, background): “The delicate balance between function and misfolding is exemplified by members of the serine protease inhibitor or serpin superfamily (Gettins, 2002; Lomas and Carrell, 2002; Law et al., 2006; Krishnan and Gierasch, 2011).”
- Lysosomal membrane permeabilization in cell death (2008, background): “Serpins (serine protease inhibitors) are a family of protease inhibitors that act either at the extracellular or at the intracellular levels (Silverman et al., 2001; Law et al., 2006).”
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (2015, background): “The serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 (SERPINA7), also known as thyroxine-binding globulin (TBG), is a protein that binds thyroid hormones thyroxin (T4) and 3,5,3’-triiodothyronine (T3) in circulation [52].”